Methicillin-resistant Staphylococcus
aureus (MRSA) is a bacterium that’s associated with several dangerous
infections. Particularly troublesome in nursing homes, hospitals and prisons,
MRSA is difficult to treat with standard types of antibiotics and, therefore,
more dangerous than other bacterial strains. While time intensive cultures have
traditionally been used to diagnose the infections, quicker tools are needed to
adequately prevent the spread of the bacteria and minimize treatment costs.
Zenosense, Inc. (OTCQB: ZENO), through the development of its low-cost
electronic “nose” device, is working to revolutionize the market.
By using a low cost gas sensor as a
starting point, Zenosense is developing an affordable diagnostic tool that acts
like a smoke alarm for MRSA. The sensor will continuously scan the air for
infection-specific volatile organic compounds (VOC), which will provide
administrators with immediate feedback that should be more effective in
containing MRSA outbreaks.
According to the CDC, MRSA infections
impact an estimated 75,000 people annually. While these patients generally have
a high survivability rate, the infections can be particularly dangerous if
compounded with other health problems. For that reason, it is imperative for
healthcare facilities to detect outbreaks of MRSA in their early stages in
order to limit their spread. Late detection of MRSA outbreaks has significant
costs and dangers. Through the use of the company’s specialized detection
device, hospitals will be able to improve their probability of early detection,
which will open the door for proactive protective measures and significantly
reduced costs.
While electronic “nose” devices
currently exist on the market, they are too bulky and expensive for widespread
use in medical facilities. Zenosense, through the continued development of its
detection device, is preparing to service a multi-billion dollar industry while
addressing substantial health and safety concerns.
The company’s MRSA device is intended
to be produced in both wearable and fixed position forms. With the company
continuing towards the completion of development, look for Zenosense to make
significant waves in the diagnostic and detection industry in the years to
come.
For more information on the company,
visit www.zenosense.net
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment